Target intelligence / Profile preview

White spot syndrome virus (WSSV) (WSSV)

Target
WSSV
Molecular classification
Viral genome, Viral envelope protein, Viral capsid protein, DNA virus
01

Overview

White spot syndrome virus (WSSV) is a large, double-stranded DNA virus and the sole member of the genus Whispovirus within the family Nimaviridae [1]. It is the causative agent of White Spot Disease (WSD), which is characterized by rapid onset and high mortality rates in a wide range of crustacean species, particularly penaeid shrimp [2]. The viral genome consists of approximately 300 kb and encodes nearly 180 open reading frames, with the gene sequences for envelope proteins like VP28 being critical for host cell attachment and entry [3].\n\nBecause crustaceans lack an adaptive immune system, therapeutic strategies focus on targeting these viral gene sequences using molecular tools like RNA interference (RNAi) to silence viral replication [4]. Experimental treatments often involve the administration of sequence-specific double-stranded RNA (dsRNA) or DNA vaccines that encode viral antigens to prime the host's innate immune defenses [5]. Additionally, small molecules and natural extracts have been explored for their ability to interfere with the expression of these viral sequences or the function of their protein products [6]. Despite significant research, the practical application of these gene-targeted therapies in aquaculture is hindered by delivery difficulties and the potential for environmental impact [7]. Monitoring the efficacy of such treatments typically involves quantifying viral DNA loads and assessing the expression of targeted viral genes [8].

Other names
WhispovirusWSSV genomeWhite spot syndrome baculovirus complex
02

Mechanism of action

RNA interference-mediated gene silencing of viral mRNA, competitive inhibition of viral envelope proteins to prevent host cell entry, and induction of innate antiviral immunity through pattern recognition receptor activation.

03

Biological functions

Viral replicationViral entryHost cell attachmentImmune evasionApoptosis induction
04

Disease associations

White spot diseaseInfectionAquaculture mortality
05

Safety considerations

Environmental persistence of nucleic acid-based treatmentsPotential for viral mutation and resistanceOff-target effects in non-target aquatic speciesRegulatory hurdles for genetically modified treatments in aquaculture
06

Interacting drugs

VP28-specific dsRNA

5 more in the full profile.

07

Biomarkers

WSSV DNA load (qPCR)VP28 protein expressionTotal hemocyte count (THC)Phenoloxidase activity

Beyond the preview

Go deeper on White spot syndrome virus (WSSV) (WSSV).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on White spot syndrome virus (WSSV) (WSSV).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call